JAMES R SULAT Insider Trading $ARTH Arch Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES R SULAT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES R SULAT. JAMES R SULAT is Director in AMAG PHARMACEUTICALS INC. ($AVM) and Director in Diadexus, Inc. ($DDXS) and Director in MAXYGEN INC ($MAXY) and Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and Director in Arch Therapeutics, Inc. ($ARTH) and Director in EXICURE, INC. ($XCUR).
JAMES R SULAT in Arch Therapeutics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of JAMES R SULAT: Director
Holdings: 1,376,813 shares
Current Value: $936,233
Latest Transaction: Jun 23 2020
$ARTH Market Capitalization: $92.55M
$ARTH Previous Close: $0.68
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES R SULAT in Arch Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVM, ARTH, DDXS, XCUR, MAXY, MNTA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | P | 0.25 | 340,910 | 85,228 | 340,910 | |
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | O | 0.18 | 454,546 | 81,818 | 0 | |
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | O | 81,818.30 | 454,546 | 37,190,171,901 | 1,376,813 | 922.3 K to 1.4 M (+49.29 %) |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.23 | 300,000 | 68,760 | 300,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.43 | 110,000 | 46,750 | 110,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 110,000 | 0 | 370,000 | 260 K to 370 K (+42.31 %) |
| Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | M | 0.37 | 30,000 | 11,100 | 0 | |
| Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | M | 0.37 | 30,000 | 11,100 | 260,000 | 230 K to 260 K (+13.04 %) |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.65 | 200,000 | 130,000 | 200,000 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 200,000 | 0 | 230,000 | 30 K to 230 K (+666.67 %) |
| May 31 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | P | 0.44 | 83,333 | 36,500 | 83,333 | |
| May 31 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | P | 0.00 | 111,111 | 0 | 868,934 | 757.8 K to 868.9 K (+14.66 %) |
| May 05 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.39 | 130,000 | 50,700 | 130,000 | |
| May 05 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Aug 20 2015 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.27 | 200,000 | 54,000 | 200,000 |
Page: 1